{
  "therapeutic_area": "immunology_inflammation",
  "generated_at": "/Users/aditya/projects/deal_finder",
  "keywords": {
    "ta_keywords": [
      "ANA", "Acute Inflammation", "Acute inflammation", "Adalimumab", "Addison disease", "Allergic", "Allergic rhinitis", "Allergy", "Alopecia areata", "ANA", "Anaphylaxis", "Angioedema", "Ankylosing spondylitis", "Anti-CCP", "Anti-cyclic citrullinated peptide", "Anti-dsDNA", "Anti-Sm", "Anti-SSA", "Anti-SSB", "Anti-thyroglobulin", "Anti-TPO", "Anti-tTG", "Anti-U1-RNP", "Antibody", "Antigen", "Antinuclear antibody", "Antiphospholipid syndrome", "Asthma", "Ataxia-telangiectasia", "Atopic dermatitis", "Atopy", "Autoantibodies", "Autoimmune", "Autoimmune Disease", "Autoimmune diseases", "Autoimmune hemolytic anemia", "Autoimmune hepatitis", "Autoimmune polyendocrine syndrome", "Autoimmune thyroiditis", "Autoimmunity", "Autoinflammatory", "B cells", "B-Cell", "Basophils", "Behcet's disease", "Biologic Therapy", "Biologic therapy", "Biologics", "Biomarkers", "BTK", "BTK inhibitor", "C-reactive protein", "C1q", "C3", "C5", "CAR T", "CAR T-cell", "CAR-T", "Chimeric antigen receptor", "CD", "CDIDP", "Celiac disease", "Checkpoint Inhibitor", "Checkpoint inhibitor", "Chemokine", "Chronic granulomatous disease", "Chronic Inflammation", "Chronic inflammation", "CIDP", "Clinical Trial", "Common variable immunodeficiency", "Complement", "Complement activation", "Complement inhibitors", "Corticosteroids", "Crohn's Disease", "Crohn's disease", "Cryoglobulinemia", "Cyclosporine", "Cytokine", "Cytokine Release Syndrome", "Cytokine Storm", "Cytokine storm", "Cytokines", "DMARDs", "Dendritic cells", "Dermatomyositis", "Disease-Modifying Antirheumatic Drugs", "Disease-modifying antirheumatic drugs", "EGPA", "ESR", "Eosinophils", "Eosinophilic esophagitis", "Eosinophilic granulomatosis with polyangiitis", "Erythrocyte sedimentation rate", "Etanercept", "Evans syndrome", "FcγR", "Foxp3", "Giant cell arteritis", "Goodpasture syndrome", "GPAGVHD", "Granulocyte-macrophage colony-stimulating factor", "Granulomatosis with polyangiitis", "Graves disease", "GVHD", "HLA", "HLA-B27", "Hashimoto thyroiditis", "Hereditary angioedema", "Hyper IgM syndrome", "IBD", "IFN-alpha", "IFN-gamma", "Ig", "IgA", "IgA deficiency", "IgA vasculitis", "IgE", "IgG", "IgM", "Immune", "Immune System", "Immune checkpoint", "Immune response", "Immune thrombocytopenic purpura", "Immune tolerance", "Immune-mediated", "Immunodeficiency", "Immunogenicity", "Immunoglobulin", "Immunology", "Immuno-oncology", "Immunomodulators", "Immunosuppressant", "Immunosuppressants", "Immunosuppression", "Immunosuppressive therapy", "Immunotherapy", "Inflammasome", "Inflammation", "Inflammatory", "Inflammatory Bowel Disease", "Inflammatory Response", "Inflammatory bowel disease", "Infliximab", "Interferon-alpha", "Interferon-gamma", "Interleukin", "Interleukin inhibitors", "Interleukins", "ITP", "JAK Inhibitor", "JAK inhibitor", "Juvenile idiopathic arthritis", "Lupus", "Mast cells", "MHC", "Microscopic polyangiitis", "Mixed connective tissue disease", "Monoclonal Antibody", "Monoclonal antibody", "Monocytes", "MS", "Multiple sclerosis", "Myasthenia gravis", "Myeloperoxidase", "NLRP3", "NETs", "NK cells", "NSAIDs", "Natural killer cells", "Neutrophil extracellular traps", "Neutrophils", "Non-Steroidal Anti-Inflammatory Drugs", "Non-steroidal anti-inflammatory drugs", "Nonsteroidal anti-inflammatory drugs", "Neuromyelitis optica", "Pernicious anemia", "PD-1", "PD-L1", "Pemphigus vulgaris", "Polymyalgia rheumatica", "Polymyositis", "Primary biliary cholangitis", "Primary sclerosing cholangitis", "Proteinase-3", "PsA", "Psoriasis", "Psoriatic arthritis", "RA", "Reactive arthritis", "Regulatory T cells", "RF", "RORγt", "Rheumatoid Arthritis", "Rheumatoid arthritis", "Rheumatoid factor", "Rituximab", "Sarcoidosis", "SCID", "Selective IgA deficiency", "Seronegative spondylarthropathy", "Sjögren syndrome", "SLE", "Scleroderma", "Small Molecule", "Small molecule", "SYK", "Systemic lupus erythematosus", "Systemic sclerosis", "T cells", "T-Cell", "TGF-beta", "Th1", "Th17", "Th2", "Thyroid peroxidase", "tTG", "Tissue transglutaminase", "TLR", "TNF-alpha", "Toll-like receptors", "Transplant rejection", "Tregs", "Type 1 diabetes", "Ulcerative Colitis", "Ulcerative colitis", "Undifferentiated connective tissue disease", "Urticaria", "Vasculitis", "Vitiligo", "Wegener granulomatosis", "Wiskott-Aldrich syndrome", "X-linked agammaglobulinemia", "c-ANCA", "p-ANCA"
    ],
    "stage_keywords": [
      "discovery stage",
      "discovery program",
      "early-stage development",
      "early development",
      "research stage",
      "R&D stage",
      "non-clinical",
      "nonclinical",
      "pre-clinical",
      "preclinical",
      "preclinical development",
      "toxicology studies",
      "IND-enabling",
      "IND filing",
      "first-in-human",
      "FIH",
      "fih",
      "phase 1",
      "phase I",
      "phase i",
      "phase-1",
      "phase 1a",
      "phase Ia",
      "phase-1a",
      "phase 1b",
      "phase Ib",
      "phase-1b",
      "initial clinical trial",
      "dose-escalation study",
      "safety and tolerability",
      "single ascending dose",
      "multiple ascending dose",
      "SAD",
      "MAD",
      "healthy volunteer study",
      "human proof of concept",
      "PoC",
      "proof-of-concept"
    ],
    "deal_keywords": [
      "acquired",
      "acquires",
      "acquiring",
      "acquisition",
      "merger",
      "merges",
      "merged",
      "buyout",
      "takeover",
      "spinout",
      "spin-out",
      "spun out",
      "spinoff",
      "divestiture",
      "divested",
      "carve-out",
      "transaction",
      "deal",
      "agreement",
      "option agreement",
      "option to license",
      "option and license",
      "option to acquire",
      "strategic option",
      "term sheet",
      "exclusive license",
      "non-exclusive license",
      "license agreement",
      "license deal",
      "licensing",
      "licensed",
      "licenses",
      "in-license",
      "out-license",
      "co-development",
      "co commercialize",
      "co-commercialization",
      "collaboration",
      "collaborated",
      "collaborates",
      "research collaboration",
      "research alliance",
      "development partnership",
      "strategic partnership",
      "strategic alliance",
      "joint venture",
      "distribution agreement",
      "supply agreement",
      "marketing agreement",
      "equity investment",
      "minority investment",
      "stake acquisition",
      "entered into",
      "signed",
      "signs",
      "inked",
      "inks",
      "announced",
      "announces",
      "formed partnership",
      "established collaboration"
    ]
  },
  "generation_details": {
    "temperatures_used": [
      0.2,
      0.3,
      0.5,
      0.7,
      0.8
    ],
    "total_candidates": 265,
    "final_count": 100
  },
  "all_candidates": [
    {
      "temperature": 0.2,
      "keywords": [
        "Immunology",
        "Inflammation",
        "Rheumatoid Arthritis",
        "RA",
        "Psoriasis",
        "PsA",
        "Crohn's Disease",
        "CD",
        "Ulcerative Colitis",
        "UC",
        "Inflammatory Bowel Disease",
        "IBD",
        "IL-6 inhibitor",
        "JAK inhibitor",
        "Monoclonal antibody",
        "Small molecule",
        "Cytokine storm",
        "Autoimmune",
        "Immunosuppressive therapy",
        "Biologic therapy",
        "TNF-alpha",
        "IL-17",
        "IL-23",
        "Interleukin inhibitors",
        "C-reactive protein",
        "CRP",
        "Erythrocyte sedimentation rate",
        "ESR",
        "Autoantibodies",
        "Rheumatoid factor",
        "RF",
        "Anti-cyclic citrullinated peptide",
        "Anti-CCP",
        "Immunoglobulin",
        "Ig",
        "T cells",
        "B cells",
        "Immune response",
        "Infliximab",
        "Adalimumab",
        "Etanercept",
        "Corticosteroids",
        "Nonsteroidal anti-inflammatory drugs",
        "NSAIDs",
        "Methotrexate",
        "Cyclosporine",
        "Immunomodulators",
        "Antibody",
        "Antigen",
        "Autoimmunity",
        "Immunodeficiency",
        "Immunosuppression",
        "Immunotherapy"
      ]
    },
    {
      "temperature": 0.3,
      "keywords": [
        "Immunology",
        "Inflammation",
        "Rheumatoid Arthritis",
        "RA",
        "Cytokine Storm",
        "IL-6 Inhibitor",
        "JAK Inhibitor",
        "Monoclonal Antibody",
        "Small Molecule",
        "Clinical Trial",
        "Biomarkers",
        "TNF-alpha",
        "IL-17",
        "Immunosuppressant",
        "Autoimmune Disease",
        "Lupus",
        "SLE",
        "Psoriasis",
        "Crohn's Disease",
        "IBD",
        "Inflammatory Bowel Disease",
        "Ulcerative Colitis",
        "UC",
        "Biologic Therapy",
        "Corticosteroids",
        "NSAIDs",
        "Non-Steroidal Anti-Inflammatory Drugs",
        "DMARDs",
        "Disease-Modifying Antirheumatic Drugs",
        "Immunotherapy",
        "Checkpoint Inhibitor",
        "PD-1",
        "CTLA-4",
        "T-Cell",
        "B-Cell",
        "Immune System",
        "Autoimmunity",
        "Infliximab",
        "Adalimumab",
        "Etanercept",
        "Rituximab",
        "Methotrexate",
        "Cyclosporine",
        "Immunoglobulin",
        "Antibody",
        "Antigen",
        "Immunogenicity",
        "Immunosuppression",
        "Interleukin",
        "Cytokine",
        "Inflammatory Response",
        "Chronic Inflammation",
        "Acute Inflammation"
      ]
    },
    {
      "temperature": 0.5,
      "keywords": [
        "Cytokines",
        "Interleukins",
        "Immunosuppressants",
        "Autoimmune diseases",
        "Chronic inflammation",
        "Acute inflammation",
        "Rheumatoid arthritis",
        "RA",
        "Inflammatory bowel disease",
        "IBD",
        "Crohn's disease",
        "Ulcerative colitis",
        "Psoriasis",
        "Asthma",
        "Multiple sclerosis",
        "MS",
        "Lupus",
        "Systemic lupus erythematosus",
        "SLE",
        "TNF-alpha",
        "IL-6",
        "IL-17",
        "IL-1",
        "JAK inhibitor",
        "Janus kinase inhibitors",
        "Biologics",
        "Monoclonal antibodies",
        "mAbs",
        "Small molecules",
        "Immunotherapy",
        "Corticosteroids",
        "NSAIDs",
        "Non-steroidal anti-inflammatory drugs",
        "DMARDs",
        "Disease-modifying antirheumatic drugs",
        "Biomarkers",
        "CRP",
        "C-reactive protein",
        "ESR",
        "Erythrocyte sedimentation rate",
        "Immunoglobulin",
        "Autoantibodies",
        "ANAs",
        "Antinuclear antibodies",
        "Rheumatoid factor",
        "RF",
        "Anti-CCP",
        "Cyclic citrullinated peptide",
        "HLA-B27",
        "Human leukocyte antigen B27",
        "PD-L1",
        "Programmed death-ligand 1",
        "Check point inhibitors",
        "CTLA-4"
      ]
    },
    {
      "temperature": 0.7,
      "keywords": [
        "Immunology",
        "Inflammation",
        "Rheumatoid Arthritis",
        "RA",
        "IL-6 inhibitor",
        "JAK inhibitor",
        "Monoclonal antibody",
        "Small molecule",
        "Cytokines",
        "TNF-alpha",
        "Autoimmune disease",
        "Lupus",
        "SLE",
        "Inflammatory Bowel Disease",
        "IBD",
        "Crohn's disease",
        "Ulcerative colitis",
        "Interleukin-17",
        "IL-17",
        "Kinase inhibitors",
        "Biomarkers",
        "Immunosuppressants",
        "Therapeutic antibodies",
        "Psoriasis",
        "Infliximab",
        "Adalimumab",
        "Etanercept",
        "Chronic inflammation",
        "Immunotherapy",
        "Immunopathology",
        "C-reactive protein",
        "CRP",
        "Erythrocyte sedimentation rate",
        "ESR",
        "Autoantibodies",
        "Cytokine storm",
        "Corticosteroids",
        "NSAIDs",
        "Non-steroidal anti-inflammatory drugs",
        "DMARDs",
        "Disease-modifying antirheumatic drugs",
        "Biologics",
        "Immune checkpoint inhibitors",
        "Translational immunology",
        "Immunogenicity",
        "Immune response",
        "Immunosuppression",
        "Immunodeficiency",
        "Immunoglobulins",
        "Cell-mediated immunity",
        "Humoral immunity"
      ]
    },
    {
      "temperature": 0.8,
      "keywords": [
        "Immunology",
        "Inflammation",
        "Rheumatoid Arthritis",
        "RA",
        "Lupus",
        "Systemic Lupus Erythematosus",
        "SLE",
        "Psoriasis",
        "Inflammatory Bowel Disease",
        "IBD",
        "Crohn's Disease",
        "Ulcerative Colitis",
        "Cytokine Storm",
        "IL-6 Inhibitor",
        "JAK Inhibitor",
        "Monoclonal Antibody",
        "Small Molecule",
        "Autoimmune Disease",
        "Biomarkers",
        "Cytokines",
        "TNF-alpha",
        "IL-17",
        "Immunosuppressive Therapy",
        "Corticosteroids",
        "NSAIDs",
        "Nonsteroidal Anti-inflammatory Drugs",
        "Immunotherapy",
        "Anti-inflammatory Drugs",
        "Immunological Disorders",
        "CD20",
        "B Cells",
        "T Cells",
        "Immune Response",
        "Immune System",
        "Interleukins",
        "Clinical Trials",
        "FDA Approval",
        "Drug Development",
        "Pharmaceutical Companies",
        "Biotech Industry",
        "Inflammation Markers",
        "CRP",
        "C-Reactive Protein",
        "Biologics",
        "Autoimmunity",
        "Cell Mediated Immunity",
        "Humoral Immunity",
        "Immune Checkpoints",
        "PD-1",
        "CTLA-4",
        "Immunosuppressants",
        "Immune Modulators",
        "Infliximab",
        "Adalimumab"
      ]
    }
  ]
}